This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Neurologists, try using your brains first! Horowitz'¹ enthusiastic advocacy of aggressive competition with less well-trained physicians for the tissue-type plasminogen activator treatment market should not, I hope, lead us toward the tactics of used car salesmen. I agree that treatment with tissue-type plasminogen activator should be offered to the patient with fresh stroke whose computed tomographic scan shows no blood. But I believe that an ethical explanation to him/her and his/her family (not a sales pitch) should indicate the following:

1. To make your own wise decision about this new treatment, you must understand the complicated facts of our present knowledge. There are pros and cons.
   
2. There is a very good chance that without this clot-busting treatment you may recover to a significant degree, or even completely from your present situation. There is also a definite possibility that the stroke and its complications can be fatal. At this time it simply . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter